Edition:
United States

EKF Diagnostics Holdings PLC (EKF.L)

EKF.L on London Stock Exchange

20.25GBp
26 May 2017
Change (% chg)

-0.50 (-2.41%)
Prev Close
20.75
Open
20.25
Day's High
20.25
Day's Low
20.25
Volume
1,313,412
Avg. Vol
1,799,024
52-wk High
21.88
52-wk Low
10.50

Latest Key Developments (Source: Significant Developments)

EKF Diagnostics says evaluating plans to split company into two separate companies
Monday, 20 Mar 2017 03:00am EDT 

EKF Diagnostics Holdings Plc : Currently evaluating plans under which they would split company into two separate companies based on business divisions . US federal income tax chargeable on any gain associated with divestiture of business could be significant . Implementation of proposal is envisaged to include a cancellation of company's shares from trading on aim . Directors current intention to seek a listing of shares of both companies on a market to be determined . Company is evaluating possibility of a share buyback offer to shareholders .Share buyback offer would, if completed, be prior to commencement of separation and would be at a price of 21.5p per share.  Full Article

EKF Diagnostics Holdings PLC won two new tenders for Hemo Control point-of-care hemoglobin analyser
Thursday, 3 Sep 2015 02:00am EDT 

EKF Diagnostics Holdings PLC:Says that it has recently won two new tenders for its Hemo Control point-of-care hemoglobin analyser.In Turkey, EKF has been awarded a tender by the Red Crescent, the humanitarian organisation that runs the nation's blood banking service.Under the terms of the tender EKF will supply 668 Hemo Control analysers and 160,000 boxes of cuvettes over a three year period, in a contract worth a little under e1 million.The second tender has been secured by EKF's US sales team from the State of Colorado's Women, Infants and Children programme.The tender to supply Hemo Control analysers (sold in the US as HemoPoint H2) and related cuvettes is valued at $450,000 over a five year period with additional incremental tenders expected for further analyser accessories.  Full Article

More From Around the Web

BRIEF-EKF Diagnostics says evaluating plans to split company into two separate companies

* Currently evaluating plans under which they would split company into two separate companies based on business divisions